FDA Inspection 1226933 — Hospira Zagreb d.o.o.
The FDA completed an inspection of Hospira Zagreb d.o.o. on December 16, 2021 in Brdovec. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 16, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Brdovec (Croatia)
Additional Details
Mutual Recognition Agreement (MRA)